Workflow
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstaZeneca
CNBC· 2025-06-09 19:30
The Food and Drug Administration on Monday approved Merck's shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca.The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead of the RSV season that typically kicks off around fall and winter and lasts through the spring. Merck said in a release that it expects orders for the shot to begin in J ...
MUSE Microscopy, Inc. Launches Veterinary Digital Pathology with the First-of-Its-Kind Tissue-to-Direct Digital Imaging for the Veterinary Market
GlobeNewswire News Room· 2025-06-09 19:29
IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, today announced the formation of MUSE Veterinary Digital Pathology, LLC, a wholly-owned subsidiary focused on transforming pathology through point-of-care service. This initiative aims to provide same-day results for tissue biopsies. This new service will provide the gold standard of patient care allowing veterinarians to deliver pet parents with diagnosis, prognosis, and treatment plans effic ...
Science Applications International Is a Wicked Hot Buy in June
MarketBeat· 2025-06-09 19:20
Science Applications International TodaySAICScience Applications International$103.52 -1.80 (-1.71%) 52-Week Range$94.68▼$156.34Dividend Yield1.43%P/E Ratio17.47Price Target$124.20Add to WatchlistScience Applications International's NYSE: SAIC share price imploded following Donald Trump’s election to the U.S. Presidency and is now offering a screaming hot entry for investors. The implosion was caused by uncertainty surrounding the company’s primary revenue source, government spending.Get SAIC alerts:Those ...
ADAR1 Issues Statement on Keros Therapeutics' Troubling 2025 Director Election Results and Insufficient Capital Return Proposal
Prnewswire· 2025-06-09 19:12
Significant Withhold Votes from Directors Mary Ann Gray and Alpna Seth Underscores Need for Change and a More Disciplined Capital Allocation StrategyAUSTIN, Texas, June 9, 2025 /PRNewswire/ -- ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1" or "We"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company"), today issued the following statement regarding the results of the Company's 2025 Annual Meeting of Stockholders (the "Annual Meeting"):"We believe the ...
CLASS ACTION REMINDER: Berger Montague Advises Organon & Co. (NYSE: OGN) Investors to Inquire About a Securities Fraud Lawsuit by July 22, 2025
Prnewswire· 2025-06-09 19:11
PHILADELPHIA, June 9, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN) on behalf of purchasers of Organon securities between October 31, 2024 through April 30, 2025, inclusive (the "Class Period").Investor Deadline: Investors who purchased or acquired Organon securities during the Class Period may, no later than JULY 22, 2025, seek to be appointed as a lead plaintiff representative o ...
Tenaris: The Buybacks Continue
Seeking Alpha· 2025-06-09 19:07
Core Insights - The article emphasizes the importance of conducting thorough due diligence before making investment decisions, highlighting that past performance does not guarantee future results [3]. Group 1 - The content expresses that the author's opinions are personal and do not constitute investment recommendations [2]. - It is noted that the author has no financial positions in the companies mentioned, indicating a lack of conflict of interest [1]. - The article clarifies that the views expressed may not reflect those of the platform as a whole, underscoring the diversity of opinions among contributors [3].
CIVITAS RESOURCES (NYSE: CIVI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by July 1, 2025
Prnewswire· 2025-06-09 19:06
PHILADELPHIA, June 9, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Civitas Resources, Inc. ("Civitas" or the "Company") (NYSE: CIVI) on behalf of purchasers of Civitas securities between February 27, 2024 through February 24, 2025, inclusive (the "Class Period").Investor Deadline: Investors who purchased or acquired Civitas securities during the Class Period may, no later than JULY 1, 2025, seek to be appointed as a lead plaintiff re ...
Announcement by Gerdau S.A. of Consideration for Cash Tender Offer for Any and All Outstanding 4.875% Notes due 2027 issued by Gerdau Trade Inc.
Prnewswire· 2025-06-09 19:03
SÃO PAULO, June 9, 2025 /PRNewswire/ -- Gerdau S.A. ("Gerdau") (NYSE: GGB) announces the consideration to purchase for cash any and all of the outstanding 4.875% notes due 2027 (the "Notes") issued by Gerdau Trade Inc. ("Gerdau Trade"), fully, unconditionally and irrevocably guaranteed by Gerdau (by itself and as successor in interest of Gerdau Aços Especiais S.A.), Gerdau Açominas S.A. and Gerdau Aços Longos S.A. (together, the "Guarantors") (the "Offer").The Offer is being made pursuant to the terms and s ...
Here's Why Archer Aviation Stock Is Soaring Today
The Motley Fool· 2025-06-09 18:58
The trail ahead for this whole new industry continues to be cleared.Shares of Archer Aviation (ACHR 10.50%) rekindled their choppy recovery rally today, up 11.7% as of 2:33 p.m. ET. While the reason for the big move doesn't directly translate into real revenue or profit progress, it certainly makes both much more likely than was first anticipated.An executive order further clears a trailCredit President Donald Trump, mostly. With an executive order signed late Friday, the U.S. president has hastened the adv ...
Why Intuitive Surgical Stock Plunged Today
The Motley Fool· 2025-06-09 18:54
One former Intuitive Surgical fan thinks it's time to sell the stock.Intuitive Surgical (ISRG -5.44%), the maker of surgical robots and tools for robotic surgery, is taking it on the chin in afternoon trading Monday. Through 2:22 p.m. ET, Intuitive stock has lost 5.5% of its value.You can blame Deutsche Bank for that. What Deutsche says about Intuitive SurgicalDeutsche Bank downgraded Intuitive Surgical stock to "sell" this morning, with a $440 price target implying more than 16% downside."Intuitive's da Vi ...